Pmv Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +0.8% | +2.8% | -0.3% | -89.5% | -5.1% | -13.5% | -3.1% | +6.5% | +3.0% | -29.4% | – | |
| – | -10.8% | -12.0% | +6.0% | -19.6% | -42.9% | +18.6% | +10.6% | -17.1% | -1.3% | +2.0% | +10.8% | – | |
| – | – | -194.2% | – | – | +22.1% | -206.2% | – | -72.7% | -97.5% | -20,538.5% | – | – | |
| – | +347.7% | +201.5% | -99.3% | -75.0% | +5,500.0% | -92.9% | +175.0% | -90.9% | +1,400.0% | -100.0% | – | – | |
| – | -92.3% | – | -91.1% | +636.9% | -54.8% | +270.8% | -61.7% | +9.5% | +53.3% | +12.9% | -158.7% | – | |
| – | -99.1% | -100.0% | – | -100.0% | – | -94.2% | +930.0% | -100.0% | – | -100.0% | – | – | |
| – | – | – | -91.2% | -67.4% | -3,183.1% | – | -168.9% | – | – | -30.3% | -2,424.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.